Search For
/
Stocks
Intraday Booster
Sector Booster
Stock Screener
Market Pulse
Screeners
More
Go Prime
My Plans
Privacy Policy
Contact
Refer & EarnScreenersMain
Stock Screener
Create Screener
Explore Screeners
Community ScreenersTrading Screeners
CandleSticks Screener
Top Gainers & Losers
Opening Range Breakout
Stock Screener AI
Stock Quality Scorecard
Overvalued StocksNewUndervalued StocksNewTechnical Screeners
NR4 Stocks
NR7 Stocks
Previous Day High Breakout
Previous Day Low Breakout
Previous Day Open Breakout
Bullish Crossover Stocks
Bearish Crossover Stocks
High Volume Shocker
VWAP Breakout Stocks
Range High Breakout
Range Low BreakoutMoreMarkets
Global Market Today
Global Indices
Indian Indices
NIfty TodaySmart Money
FII DII DataNew
FII Buying
NSE Insider Trading
SLB Stocks DataDerivatives
FnO Movements
NSE F&O Lot Size
Ban ListAnalysis & Calendars
Technical DashboardSector Booster
Sector AnalysisNew
Result Calendar
Economic Calendar
JHS Svendgaard Laboratories
Small Cap•250 Employees•IPO 2006
Current Price
₹8.48
-0.49 (-5.46%)Updated
Today's Range
8.41
₹8.48
9.35
52 Week Range
52W Low₹8.15
52W High₹16.46
₹8.48
Downside4.05%
Upside94.10%
Price Chart
Compare with Peers
Historical Ratios
Track top 12 most important financial ratios
P/E Ratio: Price to Earnings - Most used valuation metric
Loading chart...
Analyzing Investment Quality
Processing 9 key metrics...
Key Metrics
Hover for details
Valuation
Market Cap
₹86.89 Cr
Market Cap
Total market value of companyP/E Ratio
-
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)P/B Ratio
0.53
P/B Ratio
Price to Book Value. <3 may indicate undervaluationEPS
₹-0.93
EPS
Earnings Per Share. Higher and growing is positiveProfitability
ROE
-4.13%
ROE
Return on Equity. >15% is good, >20% is excellentROCE
-5.19%
ROCE
Return on Capital Employed. >15% is goodNet Margin
-8.48%
Net Margin
Net profit as % of revenue. >10% is goodOperating Margin
-%
Operating Margin
Operating profit margin. >15% is goodGrowth
EPS Growth (5Y)
-%
EPS Growth (5Y)
5-year EPS growth. >15% is strongRevenue Growth (5Y)
-5.81%
Revenue Growth (5Y)
5-year revenue growth. >10% is goodQtr Sales Growth
-4.21%
Qtr Sales Growth
Quarter-over-quarter sales growthQtr Profit Growth
268.00%
Qtr Profit Growth
Quarter-over-quarter profit growthFinancial Health
Debt/Equity
0.03
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellentBook Value
₹21.67
Book Value
Net asset value per shareDividend Yield
-%
Dividend Yield
Annual dividend as % of price. >2% is goodPromoter Holding
34.60%
Promoter Holding
Promoter stake. >50% shows confidenceGood
Average
Needs Attention
SWOT Analysis
Strengths
3 points- •JHS Svendgaard Laboratories Ltd has demonstrated impressive quarterly profit growth, with its latest net profit increasing by a substantial 268% to 1.06 Cr, indicating a strong turnaround in recent performance.
- •The company maintains a very healthy financial structure with an extremely low debt-to-equity ratio of just 0.04, suggesting minimal reliance on borrowed capital and strong balance sheet health.
Weaknesses
7 points- •The company exhibits poor capital efficiency with negative returns on equity (-10.80%) and capital employed (-5.19%), indicating it is not generating sufficient returns from its investments.
- •JHS Svendgaard Laboratories Ltd reported a significant trailing twelve-month net loss of -15.2 Cr, highlighting persistent profitability challenges despite recent quarterly gains.
Opportunities
3 points- •Operating in the Fast Moving Consumer Goods (FMCG) and Personal Care sectors, the company stands to benefit from increasing consumer demand and market expansion in these resilient industries.
- •Given its relatively small market capitalization of 107 Cr compared to industry giants, JHS has substantial room to grow and capture market share through strategic initiatives and product innovation.
Threats
4 points- •The company faces intense competition from well-established industry giants like Godrej Consumer, Dabur, and Colgate-Palmolive, which possess significantly larger market shares and resources.
- •General market volatility and economic slowdowns pose a significant threat, potentially impacting consumer spending on personal care products and further pressuring the company's sales.
Segment-wise Financial Analysis
Fetching Financials...
Fetching Balance Sheet...
Fetching Cash Flow...
Shareholding Pattern
Loading shareholding data...
Company Insider Trading Activity
No insider trading data available
Corporate Action
Company Announcements
Technical Analysis & Indicators
Standard pivot points - most widely used
Pivot Points (CLASSIC)
| Level | Price | Distance | % Change |
|---|---|---|---|
| R4 | ₹10.96 | +₹2.48 | +29.28% |
| R3 | ₹10.02 | +₹1.54 | +18.20% |
| R2 | ₹9.69 | +₹1.21 | +14.23% |
| R1 | ₹9.08 | +₹0.60 | +7.11% |
| PIVOT | ₹8.75 | 0.27 | 3.14% |
| CURRENT | ₹8.48 | - | - |
| S1 | ₹6.26 | -₹2.22 | -26.14% |
| S2 | ₹7.20 | -₹1.28 | -15.06% |
| S3 | ₹7.81 | -₹0.67 | -7.94% |
| S4 | ₹8.14 | -₹0.34 | -3.97% |
CPR Levels
Support
Resistance
S4
N/A
S3
N/A
S2
N/A
S1
N/A
| CPR |
BC: N/AP: N/ATC: N/A
R1
N/A
R2
N/A
R3
N/A
R4
N/A
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment
is trading CPR, indicating
● CPR Width
CPR is
● Opening Range
Day's range: ~
● Price Position
Trading Inside opening range
Delivery Volume Analysis & Trading Activity
Latest Volume+100.6% vs avg
2.16L
(13 Mar 2026)Delivery %-5.7% vs avg
64.3%
(13 Mar 2026)Avg Volume (20D)20-day average
1.08L
(13 Feb - 13 Mar)Avg Delivery %Trend ↑
70.0%
(13 Feb - 13 Mar)Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.
Peer Comparison & Industry Benchmarking
Quick Compare
Largest by Market Cap
Hindustan Unilever Ltd
5.43L ₹ Cr
Best Profit Growth
Hindustan Unilever Ltd
-2.14 %
Highest Dividend Yield
Hindustan Unilever Ltd
2.30 %
Peer Comparison
| Company Name |
|---|
 Hindustan Unilever Ltd |
About
JHS Svendgaard Laboratories Ltd
JHS Svendgaard Laboratories Limited is an Indian company primarily engaged in the manufacturing, trading, and sale of oral and dental care products for both adults and children. Their product portfolio is extensive and caters to a broad market segment.
The company's own brands include a diverse range of oral hygiene products such as toothbrushes, toothpastes, and mouthwashes. Beyond oral care, JHS also produces hand sanitizers, laundry detergents, room fresheners, and denture tablets. These products are marketed under various brand names, showcasing their strategic approach to market penetration and brand diversification. Some of their key brands include Dr. Gold, Dr. Fresh, Boots, Lavoris, Peanuts, and others.
A significant aspect of JHS's business model is contract manufacturing. They provide manufacturing services for other brands' oral care products, indicating a capacity for large-scale production and a strong position within the industry's supply chain. This diversified revenue stream contributes to the company's overall financial stability and resilience.
Furthermore, JHS Svendgaard Laboratories Limited extends its reach beyond the domestic Indian market through product exports. This international presence signifies a commitment to growth and expansion into global markets, enhancing brand visibility and revenue opportunities. The company's established distribution network and relationships with major retailers and pharmacies further strengthens its market position.
Founded in 1997 and headquartered in New Delhi, JHS Svendgaard Laboratories Limited has established itself as a prominent player in India's oral and dental care sector, leveraging both its own branded products and its contract manufacturing capabilities to achieve sustained growth and market share.
COMPANY FACTS - JHS
Registered Address
B - 1/E-23, Mohan Co-operative Industrial Estate, Mathura Road
New Delhi
DELHI
IN
Tel: 911126900411
Website:https://www.svendgaard.com/
Investor Relations:http://svendgaard.com/annual_reports.html
Company Details
Group: Household & Personal Products
Sector: Consumer Staples
Industry: Personal Care Products
Exchange: NATIONAL STOCK EXCHANGE OF INDIA
Employees: 250
IPO Date: 19/10/2006
MANAGEMENT - JHS
Mr. Rajagopal Venkateish
Non-Executive Independent Chairman of the Board
Mr. Paramvir Pabla
Chief Executive Officer, Executive Director
Mr. Ashish Goel
Chief Financial Officer
Mrs. Komal Jha
Compliance Officer, Company Secretary
Mr. Nikhil Nanda
Managing Director, Executive Director
Mr. Vinay Mittal
Additional Non-Executive Non Independent Director
Mr. Kapil Minocha
Additional Non-Executive Independent Director
Mr. Mukul Pathak
Non-Executive Independent Director
Mr. Chetan Batra
Company Secretary, Compliance Officer
Investor Questions Answered
JHS Svendgaard Laboratories Ltd (JHS) Stock FAQs
Get answers to the most common questions about JHS Svendgaard Laboratories Ltd stock price, fundamentals, financial metrics, and investment analysis
The current share price of JHS Svendgaard Laboratories Ltd (JHS) is ₹8.48. Today, the stock has declined by ₹0.49 (5.46%), trading in a range of ₹8.41 to ₹9.35. The stock opened at ₹9.35 with a trading volume of 2,16,047 shares.
JHS Svendgaard Laboratories Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹86.89 crores, P/E ratio of 0.00, ROE of -4.13%, and ROCE of -5.19%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of JHS Svendgaard Laboratories Ltd (JHS) is ₹16.46, while the 52-week low is ₹8.15. Currently trading at ₹8.48, the stock is 4.0% away from its 52-week low and 48.5% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy JHS Svendgaard Laboratories Ltd stock at ₹8.48 depends on multiple factors. The stock is currently trading with a P/E ratio of 0.00 and P/B ratio of N/A. Today's performance shows a loss of 5.46%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
JHS Svendgaard Laboratories Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹8.48, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
JHS Svendgaard Laboratories Ltd's key financial metrics include: P/E Ratio: 0.00, P/B Ratio: N/A, ROE: -4.13%, ROCE: -5.19%, Dividend Yield: 0.00%, EPS: ₹-0.93, Book Value: ₹21.67, Debt-to-Equity: 0.03, and Current Ratio: N/A. The company's market cap stands at ₹86.89 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
JHS Svendgaard Laboratories Ltd stock opened at ₹9.35 and is currently trading at ₹8.48, showing a decline of ₹0.49 (5.46%). The intraday high is ₹9.35 and low is ₹8.41. The trading volume stands at 2,16,047 shares, indicating moderate market participation today.
JHS Svendgaard Laboratories Ltd has a Price-to-Earnings (P/E) ratio of 0.00, which means investors are willing to pay ₹0.00 for every ₹1 of earnings. With an EPS of ₹-0.93, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
JHS Svendgaard Laboratories Ltd has a market capitalization of ₹86.89 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹8.48) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
JHS Svendgaard Laboratories Ltd has a book value of ₹21.67 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹8.48, which is 60.9% below the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
JHS Svendgaard Laboratories Ltd has a Return on Equity (ROE) of -4.13% and Return on Capital Employed (ROCE) of -5.19%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
JHS Svendgaard Laboratories Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
JHS Svendgaard Laboratories Ltd has a debt-to-equity ratio of 0.03, which measures the company's financial leverage by comparing total debt to shareholders' equity. A low ratio suggests conservative financing with minimal debt. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
JHS Svendgaard Laboratories Ltd has an Earnings Per Share (EPS) of ₹-0.93, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹8.48 and P/E ratio of 0.00, investors are paying 0.00 times the annual earnings per share. The company may need to improve its earnings performance. Track EPS growth over quarters to assess earnings momentum.
JHS Svendgaard Laboratories Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
JHS Svendgaard Laboratories Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze JHS Svendgaard Laboratories Ltd stock, consider: 1) Fundamental Analysis - Review P/E (0.00), ROE (-4.13%), debt-to-equity (0.03), and growth rates. 2) Technical Analysis - Check 52-week range (₹8.15 - ₹16.46), moving averages, and chart patterns. 3) Valuation - Compare current price (₹8.48) with book value (₹21.67) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of JHS Svendgaard Laboratories Ltd share is ₹10.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹8.48 is -15x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in JHS Svendgaard Laboratories Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹8.15 - ₹16.46). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.03 indicates leverage. 4) Liquidity Risk - Based on trading volume of 2,16,047 shares. 5) Valuation Risk - P/E of 0.00 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
JHS Svendgaard Laboratories Ltd operates in the industry with key metrics: P/E ratio of 0.00, ROE of -4.13%, market cap of ₹86.89 crores, and dividend yield of 0.00%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.03), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for JHS Svendgaard Laboratories Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹8.48, with a 52-week range of ₹8.15 to ₹16.46. Based on fundamentals like P/E (0.00), ROE (-4.13%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling JHS Svendgaard Laboratories Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹8.48. 2) Fundamental Deterioration - Declining ROE (currently -4.13%), increasing debt (D/E: 0.03), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for JHS Svendgaard Laboratories Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.00%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.
Menu